This site is an archive of a closed Robert Wood Johnson Foundation program, provided for educational and historical purposes. Please note that this content is not routinely updated and that contact information and social links may not work.

Transplant

Home

Glycemic control among hematopoietic cell transplant recipients aged 55 years and older

 Adults age 55 and older with hematological malignancies who require hematopoietic cell transplantation (HCT) for survival are at risk for a number of nonmalignancy-related, potentially life-threatening outcomes, often due to suboptimal immune function. Evidence is emerging regarding how abnormal glycemic levels-newly termed malglycemia-impair cells of the immune system.

Syndicate content